The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
How can P&G enable consumers to do radically more with radically less water and energy use? How can we make invisible use of water & energy visible, right at the point of use? How might we particularly address the triangle of tension that exists between improving sanitization, reducing water & energy, whilst keeping the feeling of abundance of using water?. From incremental evolution to product innovation, easy-retrofit water-infrastructure changes (taps, faucets, showerheads, etc.) and water appliances that aim at both reducing (hot) water and re-using/purifying/enriching (hot) water, we want to partner!
The 2025 MIT Japan Conference will explore future research trends at MIT, highlighting breakthroughs in key areas such as Soft Materials and Mechanics, Biomedical Innovation, and the impact of Generative AI (GAI) on the Work of the Future. Additional sessions will focus on Quantum and Silicon Photonics, Nanotechnology in materials and additive manufacturing, and the latest Machine Learning and AI tools for chemical discovery. Advances in semiconductor technology, hydrogen innovation, and electrochemistry, as well as thermofluidic interfaces, will also be featured.
Please visit the MIT ILP site for the full agenda.
Karl Koster, Executive Director, Office of Corporate Relations
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Synthetic Biology Workshop 2017 - Panel Discussion
Charles Fracchia, Founder, BioBright